Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

BACKGROUND/AIMS: Hepatic damage during transarterial chemoembolization (TACE) is a critical complication in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Apart from its role in preventing HBV reactivation, there is some evidence for the benefits of preemptive antivira...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Sun Hong, Jang, Jeong Won, Kwon, Jung Hyun, Jung, Seung Min, Jang, Bohyun, Choi, Jong Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266345/
https://www.ncbi.nlm.nih.gov/pubmed/28081589
http://dx.doi.org/10.3350/cmh.2016.0054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266345/
https://www.ncbi.nlm.nih.gov/pubmed/28081589
http://dx.doi.org/10.3350/cmh.2016.0054

Ejemplares similares